Annual Cash & Cash Equivalents
$50.49 M
-$38.27 M-43.12%
December 31, 2022
Summary
- As of February 10, 2025, ANGN annual cash & cash equivalents is $50.49 million, with the most recent change of -$38.27 million (-43.12%) on December 31, 2022.
- During the last 3 years, ANGN annual cash & cash equivalents has risen by +$44.92 million (+806.25%).
Performance
ANGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$29.22 M
-$21.27 M-42.13%
March 31, 2023
Summary
- As of February 10, 2025, ANGN quarterly cash and cash equivalents is $29.22 million, with the most recent change of -$21.27 million (-42.13%) on March 31, 2023.
- Over the past year, ANGN quarterly cash and cash equivalents has dropped by -$43.78 million (-59.98%).
Performance
ANGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANGN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.1% | -60.0% |
| 3 y3 years | +806.3% | - |
| 5 y5 years | +97.9% | +424.5% |
ANGN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.1% | at low | -67.1% | at low |
| 5 y | 5-year | -43.1% | -89.0% | -77.6% | -80.9% |
| alltime | all time | -43.1% | -97.2% | -77.6% | -92.7% |
Angion Biomedica Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $29.22 M(-42.1%) |
| Dec 2022 | $50.49 M(-43.1%) | $50.49 M(-8.4%) |
| Sep 2022 | - | $55.14 M(-13.0%) |
| Jun 2022 | - | $63.37 M(-13.2%) |
| Mar 2022 | - | $73.00 M(-17.7%) |
| Dec 2021 | $88.76 M | $88.76 M(-13.6%) |
| Sep 2021 | - | $102.74 M(-12.4%) |
| Jun 2021 | - | $117.31 M(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $130.46 M(+277.0%) |
| Dec 2020 | $34.61 M(+521.2%) | $34.61 M(+81.1%) |
| Sep 2020 | - | $19.11 M(+243.0%) |
| Dec 2019 | $5.57 M(-78.2%) | $5.57 M(+161.6%) |
| Dec 2018 | $25.51 M(+1140.1%) | - |
| Jun 2014 | - | $2.13 M(-14.8%) |
| Mar 2014 | - | $2.50 M |
| Dec 2013 | $2.06 M(+46.5%) | - |
| Dec 2012 | $1.40 M | - |
FAQ
- What is Angion Biomedica annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Angion Biomedica?
- What is Angion Biomedica annual cash & cash equivalents year-on-year change?
- What is Angion Biomedica quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Angion Biomedica?
- What is Angion Biomedica quarterly cash and cash equivalents year-on-year change?
What is Angion Biomedica annual cash & cash equivalents?
The current annual cash & cash equivalents of ANGN is $50.49 M
What is the all time high annual cash & cash equivalents for Angion Biomedica?
Angion Biomedica all-time high annual cash & cash equivalents is $88.76 M
What is Angion Biomedica annual cash & cash equivalents year-on-year change?
Over the past year, ANGN annual cash & cash equivalents has changed by -$38.27 M (-43.12%)
What is Angion Biomedica quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANGN is $29.22 M
What is the all time high quarterly cash and cash equivalents for Angion Biomedica?
Angion Biomedica all-time high quarterly cash and cash equivalents is $130.46 M
What is Angion Biomedica quarterly cash and cash equivalents year-on-year change?
Over the past year, ANGN quarterly cash and cash equivalents has changed by -$43.78 M (-59.98%)